Skip to main content
. Author manuscript; available in PMC: 2015 Dec 31.
Published in final edited form as: J Gene Med. 2012 Jun;14(6):405–415. doi: 10.1002/jgm.2604

Figure 1. Considerations for effective CAR modified T cell Immunotherapy.

Figure 1

Successful application of CAR modified T cell immunotherapy requires the consideration of several qualities, including the CAR design, tumor microenvironment, patient clinical status, and funding mechanisms required for CAR development and clinical trials.